The 2756A>G variant in the gene encoding methionine synthase: Its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study

Thrombosis Research

Volumn 110, Issue 2-3, 2003, Pages 87-91

  Klerk, Mariska ^a,b   Lievers, Karin J A ^c   Kluijtmans, Leo A J ^c   Blom, Henk J ^c   Den Heijer, Martin ^c   Schouten, Evert G ^a   Kok, Frans J ^a   Verhoef, Petra ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case control study; Coronary heart disease; Homocysteine; Meta analysis; Methionine synthase; MTR; Polymorphism

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; FOLIC ACID BLOOD LEVEL; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0142196591     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00341-4     Document Type: Article

References (31)

1. Matthews R.G., Sheppard C., Goulding C. Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur. J. Pediatr. 157(Suppl. 2):1998;S54-S59.
2. den-Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb. Haemost. 80:1998;874-877.
3. Ueland P.M., Refsum H., Beresford S.A.A., Vollset S.E. The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72:2000;324-332.
4. Brattstrom L., Wilcken D.E., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 98:1998;2520-2526.
5. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G. MTHFR 677C>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 288:2002;2023-2031.
6. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M.et al. Human methionine synthase: CDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum. Mol. Genet. 5:1996;1867-1874.
7. Van-Der-Put N.M., Van-Der-Molen E.F., Kluijtmans L.A.J., Heil S.G., Trijbels J.M.F., Eskes T.K.A.B.et al. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM. 90:1997;517.
8. Chen L.H., Liu M.L., Hwang H.Y., Chen L.S., Korenberg J., Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J. Biol. Chem. 272:1997;3628-3634.
9. Verhoef P., Kok F.J., Kluijtmans L.A., Blom H.J., Refsum H., Ueland P.M.et al. The 677C→T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis. 132:1997;105-113.
10. den-Heijer M., Blom H.J., Gerrits W.B., Rosendaal F.R., Haak H.L., Wijermans P.W.et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 345:1995;882-885.
11. te Poele-Pothoff M., van-den-Berg M., Franken D.G., Boers G.H., Jakobs C., de-Kroon I.F.et al. Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 32:1995;20.
12. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
13. Rozen R. Polymorphisms of folate and cobalamin metabolism. Carmel R., Jacobsen D.W. Homocysteine in health and disease. 2001;259-270 Cambridge Univ. Press, Cambridge.
14. Harmon D.L., Shields D.C., Woodside J.V., McMaster D., Yarnell J.W.G., Young I.S.et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Gen. Epidemiol. 17:1999;298-309.
15. Hyndman ME, Bridge PJ, Warnica JW, Fick G, Parsons, HG. Effect of heterozygosity for the methionine synthase 2756 A→G mutation on the risk for recurrent cardiovascular events. Am. J. Cardiol. 2000;86: 1144-6,A9.
16. Morita H., Kurihara H., Sugiyama T., Hamada C., Kurihara Y., Shindo T.et al. Polymorphism of the methionine synthase gene-association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arteriol. Thromb. Vasc. Biol. 19:1999;298-302.
17. D'-Angelo A., Coppola A., Madonna P., Fermo I., Pagano A., Mazzola G.et al. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene - a case-control study of patients with early-onset thrombotic events. Thromb. Haemost. 83:2000;563-570.
18. Ma J., Stampfer M.J., Christensen B., Giovannucci E., Hunter D.J., Chen J.et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B-12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol. Biomark. Prev. 8:1999;825-829.
19. Geisel J., Zimbelmann I., Schorr H., Knapp J.P., Bodis M., Hubner U.et al. Genetic defects as important factors for moderate hyperhomocysteinemia. Clin. Chem. Lab. Med. 39:2001;698-704.
20. Wang X.L., Duarte N., Cai H., Adachi T., Sim A.S., Cranney G.et al. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. Atherosclerosis. 146:1999;133-140.
21. Tsai M.Y., Welge B.G., Hanson N.Q., Bignell M.K., Vessey J., Schwichtenberg K.et al. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis. 143:1999;163-170.
22. Tsai M.Y., Bignell M., Yang F., Welge B.G., Graham K.J., Hanson N.Q. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis. 149:2000;131-137.
23. Chen J., Stampfer M.J., Ma J., Selhub J., Malinow M.R., Hennekens C.H.et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis. 154:2001;667-672.
24. Wang X.L., Cai H., Cranney G., Wilcken D.E. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease. J. Cardiovasc. Risk. 5:1998;289-295.
25. Lucock M., Daskalakis I., Briggs D., Yates Z., Levene M. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c→t methylenetetrahydrofolate reductase and 2756a→g methionine synthase genotypes. Mol. Genet. Metab. 70:2000;27-44.
26. Siri P.W., Verhoef P., Kok F.J. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J. Am. Coll. Nutr. 17:1998;435-441.
27. Verhoef P., Stampfer M.J., Buring J.E., Gaziano J.M., Allen R.H., Stabler S.P.et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am. J. Epidemiol. 143:1996;845-859.
28. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P.et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 97:1998;437-443.
29. Folsom A.R., Nieto F.J., McGovern P.G., Tsai M.Y., Malinow M.R., Eckfeldt J.H.et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the atherosclerosis risk in communities (ARIC) study. Circulation. 98:1998;204-210.
30. Pancharuniti N., Lewis C.A., Sauberlich H.E., Perkins L.L., Go R.C., Alvarez J.O.et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59:1994;940-948.
31. Zeitlin A., Frishman W.H., Chang C.J. The association of vitamin b 12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: the Bronx aging study. Am. J. Ther. 4:1997;275-281.